Strongyloidiasis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
The global prevalence of Strongyloides is unknown, but experts estimate that there are between 30–100 million infected persons worldwide, mainly in tropical and subtropical countries and is more common in the pediatric age group (ages 2-10 years).<ref name="urlCDC - Strongyloides - Epidemiology & Risk Factors">{{cite web |url=https://www.cdc.gov/parasites/strongyloides/epi.html |title=CDC - Strongyloides - Epidemiology & Risk Factors |format= |work= |accessdate=}}</ref>
The global prevalence of Strongyloides is unknown, but experts estimate that there are between 30–100 million infected persons worldwide, mainly in tropical and subtropical countries and is more common in the pediatric age group (ages 2-10 years).<ref name="urlCDC - Strongyloides - Epidemiology & Risk Factors">{{cite web |url=https://www.cdc.gov/parasites/strongyloides/epi.html |title=CDC - Strongyloides - Epidemiology & Risk Factors |format= |work= |accessdate=}}</ref><ref name="pmid25121962">{{cite journal |vauthors=Puthiyakunnon S, Boddu S, Li Y, Zhou X, Wang C, Li J, Chen X |title=Strongyloidiasis--an insight into its global prevalence and management |journal=PLoS Negl Trop Dis |volume=8 |issue=8 |pages=e3018 |year=2014 |pmid=25121962 |pmc=4133206 |doi=10.1371/journal.pntd.0003018 |url=}}</ref>


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Revision as of 14:18, 26 June 2017

Strongyloidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Strongyloidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Strongyloidiasis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Strongyloidiasis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Strongyloidiasis epidemiology and demographics

CDC on Strongyloidiasis epidemiology and demographics

Strongyloidiasis epidemiology and demographics in the news

Blogs on Strongyloidiasis epidemiology and demographics

Directions to Hospitals Treating Strongyloidiasis

Risk calculators and risk factors for Strongyloidiasis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

The global prevalence of Strongyloides is unknown, but experts estimate that there are between 30–100 million infected persons worldwide, mainly in tropical and subtropical countries and is more common in the pediatric age group (ages 2-10 years).[1][2]

Epidemiology and Demographics

Incidence and Prevalance

  • The global prevalence of Strongyloides is unknown, but experts estimate that there are between 30–100 million infected persons worldwide.
  • In the United States, a series of small studies in select populations have shown that between 600-1000 per 100,000 persons sampled were infected.
  • Studies in immigrant populations have shown a much higher percentage of infected persons ranging from 460-1000 per 100.000 persons.

Geographic distrubution

  • Strongyloides is known to exist on all continents except for Antarctica, but it is most common in the tropics, subtropics, and in warm temperate regions.

Age

Ascariasis occur in all age groups but it is more common in the pediatric age group (ages 2-10 years).

Gender

Males and females are equally affected.

References

  1. "CDC - Strongyloides - Epidemiology & Risk Factors".
  2. Puthiyakunnon S, Boddu S, Li Y, Zhou X, Wang C, Li J, Chen X (2014). "Strongyloidiasis--an insight into its global prevalence and management". PLoS Negl Trop Dis. 8 (8): e3018. doi:10.1371/journal.pntd.0003018. PMC 4133206. PMID 25121962.

Template:WH Template:WS